We’re investing in smarter access pathways, scalable technology, connected insights and more efficient operational models that remove friction for industry stakeholders. And at the center of every advancement is a patient navigating a complex condition and a care team supporting them.

We’re not just moving the specialty industry forward — we’re moving it forward in a way that keeps patients at the heart of every solution, every innovation and every partnership.

Visit booth #1429 to meet with the Cardinal Health team on a variety of trending topics in specialty therapies.

Attend our speaking session

Wednesday, April 29, 2026 | 9 a.m. PT

The Evolution of Advanced Therapies: How specialty pharmacies and community providers are improving access to patient care

As the advanced therapy market evolves, the industry must adapt to improve patient access. This panel will explore the current and future state of advanced therapies, the role of health economics and real-world evidence, how manufacturers, providers and specialty pharmacies collaborate to meet key challenges, differences between community settings and academic centers, emerging specialty pharmacy trends, and more. Join this session for timely insights you won't want to miss.

Speakers:

Fran Gregory, PharmD, MBA, VP, Emerging Therapies Cardinal Health

Fran is responsible for cell & gene therapies and biosimilars at Cardinal Health. Her background includes extensive clinical, health economics and outcomes research, trade and commercial experience in the payer/PBM, specialty pharmacy and biotech manufacturer spaces. Her career reflects a consistent focus on complex, innovative, high-value pharmaceuticals, and a passion for breaking down barriers to access and care. She holds a Doctor of Pharmacy from University of Cincinnati, a Master of Business Administration from Xavier University and a Bachelor of Science from University of Cincinnati.

Leigh A Denny, PharmD, Senior Director, Value and Evidence Scientific Engagement Johnson & Johnson

Leigh specializes in health economics and outcomes research, translational science, oncology and competitive strategy, clinical account management, and has a history in Hospital and Specialty Pharmacy leadership. Dr. Denny earned her undergraduate and Pharm.D. degrees from Purdue University. She began her career in long term care consulting, MCO Owned specialty pharmacy operations, clinical hospital pharmacy and IDN leadership, serving as a Director of Pharmacy before moving into her 18 year experience in pharmaceutical industry.

Philip Marjon, MD, MS, Physician California Cancer Associates for Research & Excellence

Dr. Philip Marjon earned his M.D. from the University on NM School of Medicine, followed by residency at Lankenau Medical Center and a Hematology/Oncology fellowship at Boston University RWMC. He is board-certified in Internal Medicine, Oncology, and Hematology. He now practices in Southern California with cCARE Navista and is focused on bringing clinical trials and modern therapies. Driven by personal experience, Dr. Marjon has contributed to significant research in tumor signaling and immunotherapy published in journals like Molecular Cancer and Leukemia.